— Know what they know.
Not Investment Advice
Also trades as: ZEN.V (TSXV) · $vol 0M

ZTEK NASDAQ

Zentek Ltd.
1W: -28.8% 1M: +45.2% 3M: +21.4% YTD: +7.0% 1Y: -55.3% 3Y: -50.4% 5Y: -56.4%
$0.65
-0.07 (-10.03%)
 
Weekly Expected Move ±30.9%
$0 $0 $1 $1 $1
NASDAQ · Healthcare · Medical - Instruments & Supplies · Alpha Radar Neutral · Power 61 · $69.6M mcap · 103M float · 0.297% daily turnover · Short 61% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$69.6M
52W Range0.4-1.62
Volume148,849
Avg Volume304,553
Beta0.31
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOMohammed Jiwan
Employees24
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2012-04-02
Websitezentek.com
1205 Amber Drive
Guelph, ON P7B 6M4
CA
844 730 9822
About Zentek Ltd.

Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms